309 related articles for article (PubMed ID: 37505691)
1. The Growing Importance of Three-Dimensional Models and Microphysiological Systems in the Assessment of Mycotoxin Toxicity.
Zingales V; Esposito MR; Torriero N; Taroncher M; Cimetta E; Ruiz MJ
Toxins (Basel); 2023 Jun; 15(7):. PubMed ID: 37505691
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional (3D) cell culture studies: a review of the field of toxicology.
İpek S; Üstündağ A; Can Eke B
Drug Chem Toxicol; 2023 May; 46(3):523-533. PubMed ID: 35450503
[TBL] [Abstract][Full Text] [Related]
3. Three dimensional spheroid cell culture for nanoparticle safety testing.
Sambale F; Lavrentieva A; Stahl F; Blume C; Stiesch M; Kasper C; Bahnemann D; Scheper T
J Biotechnol; 2015 Jul; 205():120-9. PubMed ID: 25595712
[TBL] [Abstract][Full Text] [Related]
4. From animal testing to
Reyes DR; Esch MB; Ewart L; Nasiri R; Herland A; Sung K; Piergiovanni M; Lucchesi C; Shoemaker JT; Vukasinovic J; Nakae H; Hickman J; Pant K; Taylor A; Heinz N; Ashammakhi N
Lab Chip; 2024 Feb; 24(5):1076-1087. PubMed ID: 38372151
[TBL] [Abstract][Full Text] [Related]
5. Advanced biomedical applications based on emerging 3D cell culturing platforms.
Wang A; Madden LA; Paunov VN
J Mater Chem B; 2020 Dec; 8(46):10487-10501. PubMed ID: 33136103
[TBL] [Abstract][Full Text] [Related]
6. Three-Dimensional Liver Culture Systems to Maintain Primary Hepatic Properties for Toxicological Analysis In Vitro.
Kammerer S
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638555
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro--implication for drug development.
Ekert JE; Johnson K; Strake B; Pardinas J; Jarantow S; Perkinson R; Colter DC
PLoS One; 2014; 9(3):e92248. PubMed ID: 24638075
[TBL] [Abstract][Full Text] [Related]
8. Fish hepatocyte spheroids - A powerful (though underexplored) alternative in vitro model to study hepatotoxicity.
Alves RF; Rocha E; Madureira TV
Comp Biochem Physiol C Toxicol Pharmacol; 2022 Dec; 262():109470. PubMed ID: 36122680
[TBL] [Abstract][Full Text] [Related]
9. Modeling immunity in microphysiological systems.
Kwee BJ; Li X; Nguyen XX; Campagna C; Lam J; Sung KE
Exp Biol Med (Maywood); 2023 Nov; 248(22):2001-2019. PubMed ID: 38166397
[TBL] [Abstract][Full Text] [Related]
10. Recent Progress in Hepatocyte Culture Models and Their Application to the Assessment of Drug Metabolism, Transport, and Toxicity in Drug Discovery: The Value of Tissue Engineering for the Successful Development of a Microphysiological System.
Tetsuka K; Ohbuchi M; Tabata K
J Pharm Sci; 2017 Sep; 106(9):2302-2311. PubMed ID: 28533121
[TBL] [Abstract][Full Text] [Related]
11. Advances in the formation, use and understanding of multi-cellular spheroids.
Achilli TM; Meyer J; Morgan JR
Expert Opin Biol Ther; 2012 Oct; 12(10):1347-60. PubMed ID: 22784238
[TBL] [Abstract][Full Text] [Related]
12. Development of an in vitro neuroblastoma 3D model and its application for sterigmatocystin-induced cytotoxicity testing.
Zingales V; Torriero N; Zanella L; Fernández-Franzón M; Ruiz MJ; Esposito MR; Cimetta E
Food Chem Toxicol; 2021 Nov; 157():112605. PubMed ID: 34634377
[TBL] [Abstract][Full Text] [Related]
13. Navigating Through Cell-Based In vitro Models Available for Prediction of Intestinal Permeability and Metabolism: Are We Ready for 3D?
Franco YL; Da Silva L; Cristofoletti R
AAPS J; 2021 Nov; 24(1):2. PubMed ID: 34811603
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in microarray 3D bioprinting for high-throughput spheroid and tissue culture and analysis.
Shrestha S; Lekkala VKR; Acharya P; Siddhpura D; Lee MY
Essays Biochem; 2021 Aug; 65(3):481-489. PubMed ID: 34296737
[TBL] [Abstract][Full Text] [Related]
15. Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systems.
Hughes DJ; Kostrzewski T; Sceats EL
Exp Biol Med (Maywood); 2017 Oct; 242(16):1593-1604. PubMed ID: 28504617
[TBL] [Abstract][Full Text] [Related]
16. Vascular microphysiological systems.
Shelton SE
Curr Opin Hematol; 2024 May; 31(3):155-161. PubMed ID: 38236999
[TBL] [Abstract][Full Text] [Related]
17. Microphysiological systems to study colorectal cancer: state-of-the-art.
Ramos P; Carvalho MR; Chen W; Yan LP; Zhang CH; He YL; Reis RL; Oliveira JM
Biofabrication; 2023 Apr; 15(3):. PubMed ID: 36888998
[TBL] [Abstract][Full Text] [Related]
18. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation.
Rubiano A; Indapurkar A; Yokosawa R; Miedzik A; Rosenzweig B; Arefin A; Moulin CM; Dame K; Hartman N; Volpe DA; Matta MK; Hughes DJ; Strauss DG; Kostrzewski T; Ribeiro AJS
Clin Transl Sci; 2021 May; 14(3):1049-1061. PubMed ID: 33382907
[TBL] [Abstract][Full Text] [Related]
19. Pre-clinical 2D and 3D toxicity response to a panel of nanomaterials; comparative assessment of NBM-induced liver toxicity.
Tutty MA; Vella G; Prina-Mello A
Drug Deliv Transl Res; 2022 Sep; 12(9):2157-2177. PubMed ID: 35763196
[TBL] [Abstract][Full Text] [Related]
20. Fingerprinting Metabolic Activity and Tissue Integrity of 3D Lung Cancer Spheroids under Gold Nanowire Treatment.
Hashemzadeh H; Kelkawi AHA; Allahverdi A; Rothbauer M; Ertl P; Naderi-Manesh H
Cells; 2022 Jan; 11(3):. PubMed ID: 35159286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
